Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: clinical characteristics and progression to carcinoid tumour.

Authors :: Sun TY
Hwang G
Pancirer D
Hornbacker K
Codima A
Lui NS
Raj R
Kunz P
Padda SK
Source :: The European respiratory journal [Eur Respir J] 2022 Jan 27; Vol. 59 (1). Date of Electronic Publication: 2022 Jan 27 (Print Publication: 2022).
Publication Year :: 2022
Abstract: Competing Interests: Conflict of interest: T.Y. Sun has nothing to disclose. Conflict of interest: G. Hwang has nothing to disclose. Conflict of interest: D. Pancirer has nothing to disclose. Conflict of interest: K. Hornbacker has nothing to disclose. Conflict of interest: A. Codima has nothing to disclose. Conflict of interest: N.S. Lui reports research funding from the Intuitive Foundation and Auspex Diagnostics. Conflict of interest: R. Raj has nothing to disclose. Conflict of interest: P. Kunz has nothing to disclose. Conflict of interest: S.K. Padda reports research funding from Epicentrx, Bayer and Boehringer Ingelheim, and served on the advisory boards of Blueprint, AstraZeneca and G1 Therapeutics.

Subjects :: Humans
Hyperplasia
Lung diagnostic imaging
Lung pathology
Carcinoid Tumor diagnosis
Lung Neoplasms pathology
Neuroendocrine Cells pathology

Full Text Access

Tools